Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event.

By T. Berger, P. Rubner, F. Schautzer, R. Egg, H. Ulmer, I. Mayringer, E. Dilitz, F. Deisenhammer, M. Reindl. New England Journal of Medicine, 2003

648 citations recorded by the source corpus.

Subfields: Developmental Neuroscience, Neurology, Pathology and Forensic Medicine

View Paper: https://www.semanticscholar.org/paper/88dc3fcb97af596ebe8b1ed68b1989f961ef05c2

Citations in the corpus

• Immunology of multiple sclerosis. (2005, neutral): “Serum anti-MOG antibodies in patients with first CNS symptoms of MS and MRI lesions are predictive of subsequent exacerbations and the diagnosis of definitive MS (251); however, because anti-MOG antibodies are also frequent in controls, important questions remain.”